Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Alan Meds vs NexLife

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.7

Alan Meds

Best for budget-conscious shoppers
★★★3.9

Starting at $99/mo

CompoundedSemaglutideTirzepatideOral Format
Visit Alan Meds
7.0

NexLife

Best for pharmacy-quality-conscious patients seeking LegitScript + NABP-certified compounded GLP-1
★★★3.5

Starting at $145/mo

Compounded SemaglutideCompounded TirzepatideLegitScript VerifiedNABP-Accredited Pharmacies
Visit NexLife

Side-by-Side Comparison

FeatureAlan MedsNexLife
Overall Score7.7/107.0/10
Starting Price$99/mo$145/mo
Editorial Rating3.9 ★ /53.5 ★ /5
Features5 features4 features
States Available460
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Alan Meds

Pros

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access
  • Multiple administration formats

Cons

  • Limited public information on program details

NexLife

Pros

  • LegitScript certified platform
  • Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
  • Both semaglutide and tirzepatide at competitive pricing
  • Semaglutide from $145/mo — among the lowest in the dataset

Cons

  • State availability not publicly disclosed
  • Pricing page returns 404 — exact tier pricing gated
  • Compounded only — no brand-name options
  • Also covers hormone optimization and longevity

Our Verdict

Winner: Alan MedsScore: 7.7/10

Alan Meds edges out NexLife with a higher overall score of 7.7/10 and is particularly strong for budget-conscious shoppers. NexLife remains a solid alternative, especially if you're looking for pharmacy-quality-conscious patients seeking LegitScript + NABP-certified compounded GLP-1.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.